Developer docs
API playgroundTry for free, no card

Search company profiles

Innerwell

Full company profile

uuid0000mwq

Namestring
Innerwell
Legal namestring
KBS, Inc.
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Innerwell (legal entity KBS, Inc.) is a US-based direct-to-consumer telehealth platform that delivers integrated mental health care combining traditional psychiatry, psychotherapy, at-home ketamine-assisted therapy, psychedelic integration, and EMDR. The company operates its own Innerwell App that consolidates psychiatrist scheduling, therapist matching, and patient-reported mood/symptom tracking into a single care coordination interface. Clinicians are licensed across psychiatry, psychiatric nursing, and psychotherapy with specialty training in ketamine administration, EMDR, and modalities including CBT, DBT, and psychodynamic therapy.

The platform monetizes primarily through tiered subscription ketamine programs — Foundation ($998-$1,098 for 8 ketamine experiences plus 4 clinician/therapy sessions) and Extended ($2,000-$2,100 for 24 ketamine experiences plus 6 sessions) — supplemented by per-session EMDR at $165 and traditional psychiatry/therapy services billed through insurance or out-of-network superbills. The company accepts major US insurers including United Healthcare, Anthem, Cigna, Aetna, Magellan Health, Optum, Tricare, and BlueCross BlueShield, and supports HSA/FSA payments with installment plans.

Innerwell serves adult consumers with treatment-resistant depression, anxiety, PTSD, OCD, trauma, and related conditions across 37+ US states. The company was founded in 2022 and closed a $3M pre-seed round led by Greycroft (with Max Ventures and Looking Glass Capital) in June 2022. Headcount is 11-50, and the company reports that 87% of patients report improvement in depression and anxiety within 4 weeks.

Short descriptiontext

Innerwell is a US direct-to-consumer telehealth platform delivering integrated mental health care, including at-home ketamine-assisted psychotherapy, psychiatry, talk therapy, EMDR, and psychedelic integration, to adults with treatment-resistant depression, anxiety, PTSD, and trauma across 37+ states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
psychedelic teletherapy, ketamine assisted therapy, telehealth psychiatry, at-home mental health, EMDR therapy services
Industry3 codes
PRIMARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAFABAC
Outpatient Mental Health & Counseling Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
NAICS code1 code
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Telehealth Mental Health Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Ketamine Therapy Programs
TypeSubscription Recurring
Description

Innerwell generates revenue through ketamine-assisted psychotherapy programs. They offer a Foundation Program with 8 ketamine experiences plus clinical sessions ($998 upfront or $1,098 in installments) and an Extended Program with 24 ketamine experiences ($2,000 upfront or $2,100 in installments).

webwire.com
2EMDR Therapy
TypeSubscription Recurring
Description

EMDR (Eye Movement Desensitization and Reprocessing) therapy sessions offered at $165 per consultation for new patients.

helloinnerwell.com
3Psychiatric Services
TypeSubscription Recurring
Description

Traditional psychiatry and therapy services providing prescription medicine programs and various psychotherapy modalities including CBT, DBT, and psychodynamic therapy.

helloinnerwell.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Foundation Ketamine Program
ModelSubscriptionBilling cadenceMonthly
Notes

8 ketamine experiences, 3 sessions with Psychiatric Clinician, 1 psychotherapy session. Priced at $998 upfront (discounted) or $1,098 standard, or 3 monthly installments of $366 each.

helloinnerwell.com
2Extended Ketamine Program
ModelSubscriptionBilling cadenceMonthly
Notes

24 ketamine experiences, 5 Psychiatric Clinician sessions, 1 psychotherapy session. Priced at $2,000 upfront (discounted) or $2,100 standard, or 4 monthly payments of $525 each.

helloinnerwell.com
3EMDR Therapy Session
ModelUnit PricingBilling cadencePay-as-you-go
Notes

EMDR therapy consultation priced at $165 per session, including evaluation by a licensed therapist and access to self-care resources via patient portal.

helloinnerwell.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Innerwell operates a direct-to-consumer telehealth platform that connects patients with licensed psychiatric clinicians and psychotherapists for at-home mental health care. Its core offerings include ketamine-assisted psychotherapy programs (Foundation and Extended tiers), traditional psychiatry with prescription management, multiple therapy modalities (CBT, DBT, psychodynamic), psychedelic integration sessions, and EMDR therapy. All services are delivered virtually with mail-delivered ketamine medication, supported by a proprietary app for mood/symptom tracking and coordinated care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 87% of patients report improvements in depression and anxiety within 4 weeks
Product overview1 text field

Innerwell is a telehealth mental health platform offering a unified suite of services including psychiatry, therapy, ketamine therapy, psychedelic integration, and EMDR. The platform connects patients with licensed psychiatric clinicians and psychotherapists through its proprietary app, providing coordinated care under one roof. The core offerings include ketamine-assisted psychotherapy programs (Foundation and Extended) alongside traditional psychiatric and talk therapy services, all delivered via telehealth with insurance acceptance.

Product and service5 records
1Psychiatry Services
CategoryCore Mental Health Service
Description

Prescription medicine programs continuously optimized based on patient mood and symptoms, delivered by psychiatric clinicians specializing in precision medicine for adults with depression, anxiety, PTSD, OCD, and related conditions.

2Therapy Services
CategoryCore Mental Health Service
Description

Psychotherapy delivered by licensed psychotherapists trained in multiple modalities including CBT, DBT, and psychodynamic therapy, available virtually on demand via Innerwell's telehealth platform.

3Ketamine Therapy
CategoryCore Mental Health Service
Description

At-home ketamine-assisted psychotherapy provided by licensed experts with specialized training in ketamine for treatment-resistant depression and anxiety, with medication shipped to patients for in-home administration.

4Psychedelic Integration
CategoryCore Mental Health Service
Description

Specialized psychotherapy sessions with licensed therapists trained to help patients process and integrate psychedelic experiences and find personal breakthroughs.

5EMDR Therapy
CategoryCore Mental Health Service
Description

Eye Movement Desensitization and Reprocessing therapy delivered by licensed experts to help patients heal past trauma, priced at $165 per consultation with access to self-care resources via the patient portal.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

BetterHelp is the largest online talk therapy platform, operating across all 50 states with a subscription teletherapy model. It serves as a broad incumbent in the general mental health teletherapy category that Innerwell's therapy arm competes with for non-ketamine patients.

TypeBroad incumbent
Description

Cerebral is a large mental health telehealth subscription platform offering therapy, psychiatry, and medication management. While facing recent regulatory scrutiny, it remains a broad incumbent in the same subscription-based, DTC virtual mental health space as Innerwell.

TypeBroad incumbent
Description

Talkiatry is a national psychiatric telehealth platform in-network with most major US insurers, providing medication management and therapy. It directly competes with Innerwell's psychiatry and therapy offerings, with substantially more funding and a broader clinician base.

TypeEmerging player
Description

Compass Pathways is a clinical-stage psychedelic therapy company developing psilocybin treatment for treatment-resistant depression. While currently research-focused rather than commercial, its eventual FDA-approved therapy could either compete with or validate Innerwell's psychedelic teletherapy model.

TypeEmerging player
Description

Lyra Health is a mental health benefits platform providing therapy, coaching, and psychiatric care to employees of large enterprises. It competes for the same treatment-resistant, high-acuity patient cohort Innerwell serves, albeit through employer-sponsored distribution rather than DTC.

6Joyous
TypeDirect peer
Description

Joyous provides at-home ketamine teletherapy focused on treatment-resistant depression with a similar subscription-based pricing model. Its direct-to-consumer model and emphasis on low-dose ketamine protocols overlap directly with Innerwell's core ketamine programs.

7Field Trip Health
TypeEmerging player
Description

Field Trip Health operates psychedelic-assisted therapy clinics and is developing at-home ketamine protocols. Its clinical psychedelic expertise and dual clinic/telehealth strategy make it a relevant adjacent competitor in psychedelic mental health treatment.

TypeEmerging player
Description

Spring Health is a fast-growing mental health platform primarily serving employers with therapy, psychiatry, and care navigation. While B2B-focused, its integrated multi-modality mental health model and expanding service portfolio overlap meaningfully with Innerwell's integrated care thesis.

TypeDirect peer
Description

Mindbloom is the closest direct competitor, offering at-home ketamine therapy for depression and anxiety with a telehealth clinician network across multiple US states. Both companies target treatment-resistant patients with mail-delivered, clinician-supervised ketamine protocols, making the product, customer base, and regulatory exposure near-identical.

TypeBroad incumbent
Description

Hims & Hers is a major consumer telehealth platform that has expanded into mental health (anxiety and depression treatment). Its scale, DTC brand, and prescribing infrastructure pose a competitive threat if it extends into ketamine or psychedelic-assisted services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Innerwell

Telehealth Mental Health Serviceshelloinnerwell.com

Innerwell is a US direct-to-consumer telehealth platform delivering integrated mental health care, including at-home ketamine-assisted psychotherapy, psychiatry, talk therapy, EMDR, and psychedelic integration, to adults with treatment-resistant depression, anxiety, PTSD, and trauma across 37+ states.

What Innerwell does

Innerwell (legal entity KBS, Inc.) is a US-based direct-to-consumer telehealth platform that delivers integrated mental health care combining traditional psychiatry, psychotherapy, at-home ketamine-assisted therapy, psychedelic integration, and EMDR. The company operates its own Innerwell App that consolidates psychiatrist scheduling, therapist matching, and patient-reported mood/symptom tracking into a single care coordination interface. Clinicians are licensed across psychiatry, psychiatric nursing, and psychotherapy with specialty training in ketamine administration, EMDR, and modalities including CBT, DBT, and psychodynamic therapy.

The platform monetizes primarily through tiered subscription ketamine programs — Foundation ($998-$1,098 for 8 ketamine experiences plus 4 clinician/therapy sessions) and Extended ($2,000-$2,100 for 24 ketamine experiences plus 6 sessions) — supplemented by per-session EMDR at $165 and traditional psychiatry/therapy services billed through insurance or out-of-network superbills. The company accepts major US insurers including United Healthcare, Anthem, Cigna, Aetna, Magellan Health, Optum, Tricare, and BlueCross BlueShield, and supports HSA/FSA payments with installment plans.

Innerwell serves adult consumers with treatment-resistant depression, anxiety, PTSD, OCD, trauma, and related conditions across 37+ US states. The company was founded in 2022 and closed a $3M pre-seed round led by Greycroft (with Max Ventures and Looking Glass Capital) in June 2022. Headcount is 11-50, and the company reports that 87% of patients report improvement in depression and anxiety within 4 weeks.

Innerwell firmographics

Firmographics
Name
Innerwell
Legal name
KBS, Inc.
Website
https://helloinnerwell.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Innerwell is a US direct-to-consumer telehealth platform delivering integrated mental health care, including at-home ketamine-assisted psychotherapy, psychiatry, talk therapy, EMDR, and psychedelic integration, to adults with treatment-resistant depression, anxiety, PTSD, and trauma across 37+ states.
Ownership category
akta.pro rank

Innerwell industry classification

Industry
Product category
Telehealth Mental Health Services
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAFABAC
Outpatient Mental Health & Counseling Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

Keywords

  • Psychedelic teletherapy
  • Ketamine assisted therapy
  • Telehealth psychiatry
  • At-home mental health
  • EMDR therapy services

Where Innerwell is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Innerwell business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Ketamine Therapy Programs: Innerwell generates revenue through ketamine-assisted psychotherapy programs. They offer a Foundation Program with 8 ketamine experiences plus clinical sessions ($998 upfront or $1,098 in installments) and an Extended Program with 24 ketamine experiences ($2,000 upfront or $2,100 in installments).
  2. EMDR Therapy: EMDR (Eye Movement Desensitization and Reprocessing) therapy sessions offered at $165 per consultation for new patients.
  3. Psychiatric Services: Traditional psychiatry and therapy services providing prescription medicine programs and various psychotherapy modalities including CBT, DBT, and psychodynamic therapy.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyFoundation Ketamine Program
SubscriptionMonthlyExtended Ketamine Program
Unit PricingPay-as-you-goEMDR Therapy Session

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Innerwell product offering

Product offering

Core offering

Innerwell operates a direct-to-consumer telehealth platform that connects patients with licensed psychiatric clinicians and psychotherapists for at-home mental health care. Its core offerings include ketamine-assisted psychotherapy programs (Foundation and Extended tiers), traditional psychiatry with prescription management, multiple therapy modalities (CBT, DBT, psychodynamic), psychedelic integration sessions, and EMDR therapy. All services are delivered virtually with mail-delivered ketamine medication, supported by a proprietary app for mood/symptom tracking and coordinated care.

Product overview

Innerwell is a telehealth mental health platform offering a unified suite of services including psychiatry, therapy, ketamine therapy, psychedelic integration, and EMDR. The platform connects patients with licensed psychiatric clinicians and psychotherapists through its proprietary app, providing coordinated care under one roof. The core offerings include ketamine-assisted psychotherapy programs (Foundation and Extended) alongside traditional psychiatric and talk therapy services, all delivered via telehealth with insurance acceptance.

Differentiator

Problem solved

Functional benefit

Products and services

  • Psychiatry Services Prescription medicine programs continuously optimized based on patient mood and symptoms, delivered by psychiatric clinicians specializing in precision medicine for adults with depression, anxiety, PTSD, OCD, and related conditions.
  • Therapy Services Psychotherapy delivered by licensed psychotherapists trained in multiple modalities including CBT, DBT, and psychodynamic therapy, available virtually on demand via Innerwell's telehealth platform.
  • Ketamine Therapy At-home ketamine-assisted psychotherapy provided by licensed experts with specialized training in ketamine for treatment-resistant depression and anxiety, with medication shipped to patients for in-home administration.
  • Psychedelic Integration Specialized psychotherapy sessions with licensed therapists trained to help patients process and integrate psychedelic experiences and find personal breakthroughs.
  • EMDR Therapy Eye Movement Desensitization and Reprocessing therapy delivered by licensed experts to help patients heal past trauma, priced at $165 per consultation with access to self-care resources via the patient portal.

Quantifiable outcome

  • 87% of patients report improvements in depression and anxiety within 4 weeks

Companies that use Innerwell

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Innerwell technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Innerwell partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Innerwell competitors and assessment

Company assessment

Broad incumbents

  • BetterHelp: BetterHelp is the largest online talk therapy platform, operating across all 50 states with a subscription teletherapy model. It serves as a broad incumbent in the general mental health teletherapy category that Innerwell's therapy arm competes with for non-ketamine patients.
  • Cerebral: Cerebral is a large mental health telehealth subscription platform offering therapy, psychiatry, and medication management. While facing recent regulatory scrutiny, it remains a broad incumbent in the same subscription-based, DTC virtual mental health space as Innerwell.
  • Talkiatry: Talkiatry is a national psychiatric telehealth platform in-network with most major US insurers, providing medication management and therapy. It directly competes with Innerwell's psychiatry and therapy offerings, with substantially more funding and a broader clinician base.
  • Hims & Hers: Hims & Hers is a major consumer telehealth platform that has expanded into mental health (anxiety and depression treatment). Its scale, DTC brand, and prescribing infrastructure pose a competitive threat if it extends into ketamine or psychedelic-assisted services.

Emerging players

  • Compass Pathways: Compass Pathways is a clinical-stage psychedelic therapy company developing psilocybin treatment for treatment-resistant depression. While currently research-focused rather than commercial, its eventual FDA-approved therapy could either compete with or validate Innerwell's psychedelic teletherapy model.
  • Lyra Health: Lyra Health is a mental health benefits platform providing therapy, coaching, and psychiatric care to employees of large enterprises. It competes for the same treatment-resistant, high-acuity patient cohort Innerwell serves, albeit through employer-sponsored distribution rather than DTC.
  • Field Trip Health: Field Trip Health operates psychedelic-assisted therapy clinics and is developing at-home ketamine protocols. Its clinical psychedelic expertise and dual clinic/telehealth strategy make it a relevant adjacent competitor in psychedelic mental health treatment.
  • Spring Health: Spring Health is a fast-growing mental health platform primarily serving employers with therapy, psychiatry, and care navigation. While B2B-focused, its integrated multi-modality mental health model and expanding service portfolio overlap meaningfully with Innerwell's integrated care thesis.

Direct peers

  • Joyous: Joyous provides at-home ketamine teletherapy focused on treatment-resistant depression with a similar subscription-based pricing model. Its direct-to-consumer model and emphasis on low-dose ketamine protocols overlap directly with Innerwell's core ketamine programs.
  • Mindbloom: Mindbloom is the closest direct competitor, offering at-home ketamine therapy for depression and anxiety with a telehealth clinician network across multiple US states. Both companies target treatment-resistant patients with mail-delivered, clinician-supervised ketamine protocols, making the product, customer base, and regulatory exposure near-identical.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Innerwell social profiles

Digital presence

Innerwell financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Innerwell leadership team

Management profile

Number of profiles

Profiles5 records

Innerwell funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Innerwell M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innerwell

What does Innerwell do?

Innerwell operates a direct-to-consumer telehealth platform that connects patients with licensed psychiatric clinicians and psychotherapists for at-home mental health care. Its core offerings include ketamine-assisted psychotherapy programs (Foundation and Extended tiers), traditional psychiatry with prescription management, multiple therapy modalities (CBT, DBT, psychodynamic), psychedelic integration sessions, and EMDR therapy. All services are delivered virtually with mail-delivered ketamine medication, supported by a proprietary app for mood/symptom tracking and coordinated care.

Is Innerwell a public or private company?

Innerwell is a private company. It is classified as venture growth investor backed and is currently operating.

When was Innerwell founded?

Innerwell was founded in 2022. It employs 11 to 50 people.

Where is Innerwell based?

Innerwell is headquartered in New York, United States, in the North America region.

How does Innerwell make money?

Three revenue lines are on record. Ketamine Therapy Programs are the primary driver. The others are EMDR Therapy and psychiatric Services.

Who are Innerwell's main competitors?

Broad incumbents on record are BetterHelp, Cerebral, Talkiatry and Hims & Hers. Emerging players are Compass Pathways, Lyra Health, Field Trip Health and Spring Health. Direct peers are Joyous and Mindbloom.

Does Innerwell have an API?

No public API is recorded for Innerwell.

What industry is Innerwell in?

Innerwell's product category is Telehealth Mental Health Services. Its primary akta.pro industry code is HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy), with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621420 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals